Clorox (NYSE:CLX) had its target price hoisted by BMO Capital Markets from $153.00 to $165.00 in a report released on Friday morning. They currently have a buy rating on the stock.
Several other equities analysts also recently commented on CLX. Bank of America upped their price objective on shares of Clorox from $130.00 to $140.00 and gave the company a neutral rating in a report on Monday, July 16th. Goldman Sachs Group cut shares of Clorox from a neutral rating to a sell rating and reduced their target price for the company from $127.00 to $112.00 in a research report on Tuesday, July 17th. They noted that the move was a valuation call. UBS Group assumed coverage on shares of Clorox in a research report on Wednesday, July 18th. They issued a sell rating and a $110.00 target price for the company. Atlantic Securities assumed coverage on shares of Clorox in a research report on Thursday, September 20th. They issued a neutral rating and a $151.00 target price for the company. Finally, ValuEngine raised shares of Clorox from a hold rating to a buy rating in a research report on Saturday, September 22nd. Four analysts have rated the stock with a sell rating, eight have given a hold rating and four have assigned a buy rating to the stock. Clorox has a consensus rating of Hold and an average target price of $141.64.
Shares of NYSE:CLX traded up $0.88 on Friday, hitting $155.08. The company had a trading volume of 23,430 shares, compared to its average volume of 1,200,947. Clorox has a 1-year low of $113.57 and a 1-year high of $155.23. The company has a market cap of $19.68 billion, a P/E ratio of 24.73, a P/E/G ratio of 3.78 and a beta of 0.28. The company has a debt-to-equity ratio of 3.38, a current ratio of 1.07 and a quick ratio of 0.65.
Clorox (NYSE:CLX) last released its quarterly earnings data on Wednesday, October 31st. The company reported $1.62 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $1.59 by $0.03. Clorox had a net margin of 13.59% and a return on equity of 102.65%. The firm had revenue of $1.56 billion for the quarter, compared to the consensus estimate of $1.53 billion. During the same period in the previous year, the company earned $1.46 earnings per share. The company’s quarterly revenue was up 4.2% on a year-over-year basis. As a group, equities research analysts expect that Clorox will post 6.31 earnings per share for the current year.
The firm also recently announced a quarterly dividend, which will be paid on Friday, November 16th. Stockholders of record on Wednesday, October 31st will be given a $0.96 dividend. The ex-dividend date of this dividend is Tuesday, October 30th. This represents a $3.84 dividend on an annualized basis and a dividend yield of 2.48%. Clorox’s payout ratio is presently 61.34%.
In other news, EVP Linda J. Rendle sold 382 shares of the business’s stock in a transaction dated Thursday, September 6th. The shares were sold at an average price of $148.32, for a total value of $56,658.24. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, SVP Michael R. Costello sold 9,265 shares of the company’s stock in a transaction dated Monday, August 13th. The stock was sold at an average price of $140.02, for a total transaction of $1,297,285.30. Following the sale, the senior vice president now directly owns 34,293 shares of the company’s stock, valued at approximately $4,801,705.86. The disclosure for this sale can be found here. In the last three months, insiders sold 29,268 shares of company stock valued at $4,196,686. 1.40% of the stock is currently owned by company insiders.
Institutional investors and hedge funds have recently bought and sold shares of the stock. Cornerstone Wealth Management LLC bought a new stake in Clorox during the second quarter worth about $105,000. Fort L.P. bought a new position in shares of Clorox in the second quarter worth about $129,000. Livingston Group Asset Management CO operating as Southport Capital Management bought a new position in shares of Clorox in the third quarter worth about $130,000. Whittier Trust Co. of Nevada Inc. lifted its holdings in shares of Clorox by 1,297.4% in the second quarter. Whittier Trust Co. of Nevada Inc. now owns 1,621 shares of the company’s stock worth $148,000 after acquiring an additional 1,505 shares during the last quarter. Finally, Legacy Advisors LLC bought a new position in shares of Clorox in the third quarter worth about $150,000. 78.35% of the stock is owned by institutional investors and hedge funds.
Clorox Company Profile
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Cleaning, Household, Lifestyle, and International. The company offers laundry additives, including bleach products under the Clorox brand, as well as Clorox 2 stain fighter and color booster; home care products primarily under the Clorox, Formula 409, Liquid-Plumr, Pine-Sol, S.O.S, and Tilex brands; naturally derived products under the Green Works brand; and professional cleaning, disinfecting, and food service products under the Clorox, Dispatch, HealthLink, Clorox Healthcare, Hidden Valley, KC Masterpiece, and Soy Vay brands.
Featured Article: Return on Equity (ROE)
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.